A novel topical gel, HT-001, shows promise as a treatment for cutaneous side effects caused by epidermal growth factor receptor inhibitor (EGFRi) cancer therapy. According to a press release ...
Gilead Sciences and LEO Pharma have entered a strategic collaboration to expedite the development and commercialisation of the latter’s small molecule oral signal transducer and activator of ...
With the Cardinals set for a minor league overhaul this year, an opportunities to blossom could present themselves for some of the organization’s younger players in 2025. From the highly rated ...